We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Groups Differ in Recommendations for Biosimilar Labeling Guidance
Industry Groups Differ in Recommendations for Biosimilar Labeling Guidance
Generic trade groups and patient advocacy organizations are taking competing stances in their recommendations for the FDA’s biosimilar labeling draft guidance.